Skip to main content

Interventional Management Strategies of Pain for the Pandemic Era

  • Chapter
  • First Online:
Headache Disorders in Pandemic Conditions

Abstract

One of the greatest disasters that mankind has experienced recently has been the COVID-19 pandemic. COVID-19 has significantly affected both social life and healthcare all over the world. Chronic pain may cause immunosuppression in some individuals. On the other hand, opioids which are the most commonly used drugs in chronic pain may have similar immunosuppressive effects on immunity and increase the risk for infections. Therefore, interventional procedures may be beneficial to avoid these risks. Interventional pain treatment procedures do not cause aerosol formation as they can generally be applied with sedoanalgesia and do not require intubation. These interventions should be applied in accordance with the use of personal protective equipment and general infection protection principles. The use of a short-acting steroid with the lowest effective dose is more reasonable during COVID-19. Regenerative medicine is safe and effective; it may be a good alternative for steroids, local anesthetics, and opioids. In general, radiofrequency and neuromodulation procedures are safe and there is no obstacle to their application in pandemics with appropriate indications. Global lockdown and restrictions of the COVID-19 pandemic have disrupted interventional pain management practices and decreased the number of pain treatment procedures.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 119.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization; weekly epidemiological update on COVID-19–1 June 2022. https://www.who.int/publications/m/item/weekly-epidemiological-update-on-COVID-19%2D%2D-1-june-2022. Accessed 15 June 2022.

  2. Lo Bianco G, Papa A, Schatman ME, Tinnirello A, Terranova G, Leoni MLG, Shapiro H, Mercadante S. Practical advices for treating chronic pain in the time of COVID-19: a narrative review focusing on interventional techniques. J Clin Med. 2021 May 25;10(11):2303. https://doi.org/10.3390/jcm10112303.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Deer TR, Sayed D, Pope JE, et al. Emergence from the COVID-19 pandemic and the Care of Chronic Pain: guidance for the Interventionalist. Anesth Analg. 2020;131(2):387–94. https://doi.org/10.1213/ANE.0000000000005000.

    Article  CAS  PubMed  Google Scholar 

  4. Murphy MT, Latif U. Pain during COVID-19: a comprehensive review and guide for the Interventionalist. Pain Pract. 2021;21(1):132–43.

    Article  PubMed  Google Scholar 

  5. Shanthanna H, Strand NH, Provenzano DA, Lobo CA, Eldabe S, Bhatia A, Wegener J, Curtis K, Cohen SP, Narouze S. Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel. Anaesthesia. 2020 Jul;75(7):935–44. https://doi.org/10.1111/anae.15076.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Gharibo C, Sharma A, Soin A, et al. Triaging interventional pain procedures during COVID-19 or related elective surgery restrictions: evidence-informed guidance from the American Society of Interventional Pain Physicians (ASIPP). Pain Physician. 2020 Aug;23(4S):S183–204.

    Article  PubMed  Google Scholar 

  7. Pergolizzi J, Boger RH, Budd K, et al. Opioids and the management of chronic severe pain in the elderly: consensus statement of an international expert panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract. 2008;8:287–313.

    Article  PubMed  Google Scholar 

  8. Nieminen TH, Hagelberg NM, Saari TI, Neuvonen M, Neuvonen PJ, Laine K, Olkkola KT. Oxycodone concentrations are greatly increased by the concomitant use of ritonavir or lopinavir/ritonavir. Eur J Clin Pharmacol. 2010;66:977–85.

    Article  CAS  PubMed  Google Scholar 

  9. McCance-Katz EF, Rainey PM, Friedland G, Jatlow P. The protease inhibitor Lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients. Clin Infect Dis. 2003;37:476–82.

    Article  CAS  PubMed  Google Scholar 

  10. Gudin J. Opioid therapies and cytochrome P450 interactions. J Pain Symptom Manag. 2012;44:S4–S14.

    Article  Google Scholar 

  11. Day M. COVID-19: ibuprofen should not be used for managing symptoms, say doctors and scientists. Br Med J. 2020;368:m1086.

    Article  Google Scholar 

  12. American Society of Regional Anesthesiology. Recommendations on chronic pain practice during the COVID-19 pandemic. https://www.asra.com/page/2903/recommendations-onchronic-pain-practice-during-the-COVID-19-pandemic. Accessed 31 March 2020.

  13. Shah S, Diwan S, Soin A, Rajput K, Mahajan A, Manchikanti L, Kaye AD, Hirsch JA, Gharibo C. Evidence-based risk mitigation and stratification during COVID-19 for return to interventional pain practice: American Society of Interventional Pain Physicians (ASIPP) guidelines. Pain Physician. 2020 Aug;23(4S):S161–82.

    Article  PubMed  Google Scholar 

  14. Centers for Disease Control and Prevention. Screening and triage at intake. Available at: https://www.cdc.gov/coronavirus/2019ncov/hcp/dialysis/screening.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fhealthcare-facilities%2Fdialysis%2Fscreening.html#screen-patients. Accessed 19 April 2020.

  15. Sheth S, Fetzer D, Frates M, Needleman L, Middleton W, Jones J, Podrasky A, Gettle LM. Guidelines for ultrasound in the radiology department during the COVID-19 pandemic. Ultrasound Q. 2020;36:200–5.

    Article  PubMed  Google Scholar 

  16. Manchikanti L. Role of neuraxial steroids in interventional pain management. Pain Physician. 2002;5:182–99.

    Article  PubMed  Google Scholar 

  17. Manchikanti L, Kosanovic R, Vanaparthy R, Vangala BP, Soin A, Sachdeva H, Shah S, Knezevic NN, Hirsch JA. Steroid distancing in interventional pain management during COVID-19 and beyond: safe. Effective and Practical Approach Pain Physician. 2020 Aug;23(4S):S319–50.

    Article  PubMed  Google Scholar 

  18. Ginzler E, Diamond H, Kaplan D, Weiner M, Schlesinger M, Seleznick M. Computer analysis of factors influencing frequency of infection in systemic lupus erythematosus. Arthritis Rheum. 1978;21:37–44.

    Article  CAS  PubMed  Google Scholar 

  19. Chakravarthy K, Strand N, Frosch A, Sayed D, Narra LR, Chaturvedi R, Grewal PK, Pope J, Schatman ME, Deer T. Recommendations and guidance for steroid injection therapy and COVID-19 vaccine administration from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2021 Mar;5(14):623–9. https://doi.org/10.2147/JPR.S302115.

    Article  Google Scholar 

  20. Shanthanna H, Busse JW, Thabane L, et al. Local anesthetic injections with or without steroid for chronic noncancer pain: a protocol for a systematic review and meta-analysis of randomized controlled trials. Syst Rev. 2016;5:18.

    Article  PubMed  PubMed Central  Google Scholar 

  21. Gharaei H, Diwan S. COVID-19 pandemic: implications on interventional pain practice–a narrative review. Pain Physician. 2020;23:S311–8.

    PubMed  Google Scholar 

  22. Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil. 2001;82:986–92.

    Article  CAS  PubMed  Google Scholar 

  23. Miller DC, Patel J, Gill J, Mattie R, Saffarian M, Schneider BJ, Popescu A, Babaria V, McCormick ZL. Corticosteroid injections and COVID-19 infection risk. Pain Med. 2020 Aug 1;21(8):1703–6. https://doi.org/10.1093/pm/pnaa199.

    Article  PubMed  Google Scholar 

  24. Lee H, Punt JA, Miller DC, et al. Do corticosteroid injections for the treatment of pain influence the efficacy of mRNA COVID-19 vaccines? Pain Med. 2021;22(4):994–1000. https://doi.org/10.1093/pm/pnab063.

    Article  PubMed  Google Scholar 

  25. Cruz FF, Rocco PRM, Pelosi P. Anti-inflammatory properties of anesthetic agents. Critical Care. 2017;21:67. https://doi.org/10.1186/s13054-017-1645-x.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Sanapati J, Manchikanti L, Atluri S, et al. Do regenerative medicine therapies provide long-term relief in chronic low back pain: a systematic review and metaanalysis. Pain Physician. 2018;21:515–40.

    PubMed  Google Scholar 

  27. Basiri A, Pazhouhnia Z, Beheshtizadeh N, Hoseinpour M, Saghazadeh A, Rezaei N. Regenerative medicine in COVID-19 treatment: real opportunities and range of promises. Stem Cell Rev Rep. 2021;17:163–75.

    Article  CAS  PubMed  Google Scholar 

  28. Cattel F, Giordano S, Bertiond C, et al. Ozone therapy in COVID-19: a narrative review. Virus Res. 2021;291:198207. https://doi.org/10.1016/j.virusres.2020.198207.

    Article  CAS  PubMed  Google Scholar 

  29. Hidalgo-Tallón FJ, Torres-Morera LM, Baeza-Noci J, Carrillo-Izquierdo MD, Pinto-Bonilla R. Updated review on ozone therapy in pain medicine. Front Physiol. 2022 Feb;23(13):840623. https://doi.org/10.3389/fphys.2022.840623.

    Article  Google Scholar 

  30. Gavazza A, Marchegiani A, Rossi G, et al. Ozone therapy as a possible option in COVID-19 management. Front Public Health. 2020;8:417. https://doi.org/10.3389/fpubh.2020.00417.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Yousefi B, Banihashemian SZ, Feyzabadi ZK, Hasanpour S, Kokhaei P, Abdolshahi A, Emadi A, Eslami M. Potential therapeutic effect of oxygen-ozone in controlling of COVID-19 disease. Med Gas Res. 2022 Apr-Jun;12(2):33–40. https://doi.org/10.4103/2045-9912.325989.

    Article  CAS  PubMed  Google Scholar 

  32. Lee DW, Pritzlaff S, Jung MJ, Ghosh P, Hagedorn JM, Tate J, Scarfo K, Strand N, Chakravarthy K, Sayed D, Deer TR, Amirdelfan K. Latest evidence-based application for radiofrequency Neurotomy (LEARN): best practice guidelines from the American Society of Pain and Neuroscience (ASPN). J Pain Res. 2021 Sep 8;14:2807–31. https://doi.org/10.2147/JPR.S325665.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Abejón D, Monzón EM, Deer T, Hagedorn JM, Araujo R, Abad C, Rios A, Zamora A, Vallejo R. How to restart the interventional activity in the COVID-19 era: the experience of a private pain unit in Spain. Pain Pract. 2020 Nov;20(8):820–8. https://doi.org/10.1111/papr.12951.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Abd-Elsayed A, Karri J, Michael A, Bryce D, Sun J, Lee M, Orhurhu V, Deer T. Intrathecal drug delivery for chronic pain syndromes: a review of considerations in practice management. Pain Physician. 2020 Nov;23(6):E591–617.

    PubMed  Google Scholar 

  35. Eldabe S, Buchser E, Duarte RV. Complications of spinal cord stimulation and peripheral nerve stimulation techniques: A review of the literature. Pain Med. 2015;17:pnv025.

    Article  Google Scholar 

  36. O'Connell NE, Ferraro MC, Gibson W, Rice AS, Vase L, Coyle D, Eccleston C. Implanted spinal neuromodulation interventions for chronic pain in adults. Cochrane Database Syst Rev. 2021 Dec 2;12(12):CD013756.

    PubMed  Google Scholar 

  37. Manchikanti L, Pampati V, Jha SS, Sanapati MR, Soin A, Shah S, Kaye AD, Hirsch JA. The impact of COVID-19 on interventional pain management practices is significant and long-lasting: an interventional pain management physician survey. Pain Physician. 2022 Mar;25(2):131–44.

    PubMed  Google Scholar 

  38. Jha S, Shah S, Calderon MD, Soin A, Manchikanti L. The effect of COVID-19 on interventional pain management practices: a physician burnout survey. Pain Physician. 2020;23:S271–82.

    PubMed  Google Scholar 

  39. Jha SS, Shah S, Calderon MD, Soin A, Manchikanti L. The effect of COVID-19 on interventional pain management practices: a physician burnout survey. Pain Physician. 2020;23:S271–82.

    PubMed  Google Scholar 

  40. Huynh L, Chang RG, Chhatre A, Sayeed Y, MacVicar J, McCormick ZL, Duszynski B, Smith C. Reopening interventional pain practices during the early phase of the COVID-19 global pandemic. Pain Med. 2021 Jul 25;22(7):1496–502. https://doi.org/10.1093/pm/pnab002.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Cetingok, H., Ozyalcin, N.S. (2023). Interventional Management Strategies of Pain for the Pandemic Era. In: Özge, A., Uludüz, D., Bolay, H., Karadaş, Ö. (eds) Headache Disorders in Pandemic Conditions . Headache. Springer, Cham. https://doi.org/10.1007/978-3-031-26309-5_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-26309-5_22

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-26308-8

  • Online ISBN: 978-3-031-26309-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics